Dergiler / İstanbul Journal of Pharmacy / 2014 / Cilt: 44 - Sayı: 1

The cyto- and genotoxic potantials of the herbal mixtures frequently used in Turkey

Sayfa
11–30
Yayın Tarihi
2015-01-29
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, the researchers and/or national authorities should consider that the use of herbal products may be harmful to human health

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Despite the profound therapeutic advantages possessed by herbs, some constituents of herbs have been shown to be potentially toxic.
📊
Temel Bulgular & Veri:For their genotoxic activities, two bacterial mutation assays, Ames assay with Salmonella typhimurium TA98 and TA100 strains and umu assay with S. thyphimurium TA1535/pSK1002 strain, were used.
💡
Sonuç & Katkı:Therefore, the researchers and/or national authorities should consider that the use of herbal products may be harmful to human health
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:herbal mixtures · Ames assay · umu assay

Özet

Despite the profound therapeutic advantages possessed by herbs, some constituents of herbs have been shown to be potentially toxic. Knowledge on their safety is inadequate although the concerns have been raised over the lack of quality controls. We aimed to determine safety of six herbal mixtures used as tea, included forty plant species, chosen on the basis of their frequency of medicinal use and commercial importance in Turkey. Their cytotoxic activities were evaluated by determining mitochondrial succinate dehydrogenase (XTT) and extracellular lactate dehydrogenase (LDH) activities on human cerviks cell line (HeLa). For their genotoxic activities, two bacterial mutation assays, Ames assay with Salmonella typhimurium TA98 and TA100 strains and umu assay with S. thyphimurium TA1535/pSK1002 strain, were used. The 50% inhibition concentration (IC) values of the extracts for LDH and XTT tests were 6.52-63.53 and 18.75-104.67 mg/mL, respectively. In the genotoxicity studies conducted by umu assay, no extracts possessed genotoxic activities at 6.25-25 mg/mL. On the contrary, Ames bacterial mutagenicity assay conducted at the same concentrations revealed that (i) some extracts were shown mutagenic activities with metabolic activation (ii) TA100 strain was more sensitive than TA98 strain to the extracts, (iii) especially, three herbal mixtures may include ingredients shown mutagenic activities both in two strains and with metabolic activation. Our findings showed that herbal teas have some significant toxic effects. Therefore, the researchers and/or national authorities should consider that the use of herbal products may be harmful to human health

Abstract

Despite the profound therapeutic advantages possessed by herbs, some constituents of herbs have been shown to be potentially toxic. Knowledge on their safety is inadequate although the concerns have been raised over the lack of quality controls. We aimed to determine safety of six herbal mixtures used as tea, included forty plant species, chosen on the basis of their frequency of medicinal use and commercial importance in Turkey. Their cytotoxic activities were evaluated by determining mitochondrial succinate dehydrogenase (XTT) and extracellular lactate dehydrogenase (LDH) activities on human cerviks cell line (HeLa). For their genotoxic activities, two bacterial mutation assays, Ames assay with Salmonella typhimurium TA98 and TA100 strains and umu assay with S. thyphimurium TA1535/pSK1002 strain, were used. The 50% inhibition concentration (IC) values of the extracts for LDH and XTT tests were 6.52-63.53 and 18.75-104.67 mg/mL, respectively. In the genotoxicity studies conducted by umu assay, no extracts possessed genotoxic activities at 6.25-25 mg/mL. On the contrary, Ames bacterial mutagenicity assay conducted at the same concentrations revealed that (i) some extracts were shown mutagenic activities with metabolic activation (ii) TA100 strain was more sensitive than TA98 strain to the extracts, (iii) especially, three herbal mixtures may include ingredients shown mutagenic activities both in two strains and with metabolic activation. Our findings showed that herbal teas have some significant toxic effects. Therefore, the researchers and/or national authorities should consider that the use of herbal products may be harmful to human health

🔖

Bu Makaleye Atıf Yap

AYGAN, A., ALPERTUNGA, B., ÖZHAN, G. (2015). The cyto- and genotoxic potantials of the herbal mixtures frequently used in Turkey. İstanbul Journal of Pharmacy, Cilt: 44 - Sayı: 1, 11–30. https://ajindex.com/articles/92751

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. WHO. (1996). Technical Report Series 863:178-184. Available at www.apps.who. int/medicinedocs/en/d/Js5516e/. Maiti B, Nagori BP, Singh R, et al. (2011). Recent trends in herbal drugs: A review. Int J Drug Res Tech 1(1):17-25.
  2. Akinboro A, Bakare AA. (2007). Cytotoxic and genotoxic effects of aqueous extracts of five medicinal plants on Allium cepa Linn. J Ethnopharmacol 112:470-475.
  3. Ernst E. (2004). Risks of herbal medicinal products. Pharmacoepidemiol Drug Safety 13:767-771.
  4. Rietjens IMCM, Boersma MG, Van der Woude H, et al. (2005). Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. Mutat Res 574:124-138.
  5. Haugen DA, Peak MJ. (1983). Mixtures of polycyclic aromatic compounds inhibit mutagenesis in the Salmonella microsome assay by inhibition of metabolic activation. Mutat Res 116:257-269.
  6. Hermann M. (1981). Synergistic effects of individual polycyclic aromatic hydrocarbons on the mutagenicity of their mixtures. Mutat Res 90:399-409.
  7. Firenzuoli F, Gori L. (2007). Herbal medicine today: clinical and research issues. J Evid Based Complement Altern Med 4:37-40.
  8. Rousseaux CG, Schachter H. (2003). Regulatory issues concerning the safety, efficacy and quality of herbal remedies. Birth Defects Res B Dev Reprod Toxicol 68:505-510.
  9. Bandaranayake WM. (2006). Quality control, screening, toxicity, and regulation of herbal drugs.Modern Phytomedicine. Turning Medicinal Plants into Drugs. Edited by I. Ahmad, F. Aqil, and M. Owais, 25-57.
  10. Bast A, Chandler RF, Choy PC, et al. (2002). Botanical health products, positioning and requirements for effective and safe use. Environ Toxicol Pharmacol 12:195-211. EMEA Ad hoc Working Group on Herbal Medicinal Products. (1999). Report from the ad hoc Working Group on Herbal Medicinal Products (EMEA/HMPWG/25/99). Working Group on Herbal Medicinal Products, London. Jordan SA, Cunningham DG, Marles RJ. (2010). Assessment of herbal medicinal products: Challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol Appl Pharmacol 243:198-216.
  11. Cakilcioglu U, Turkoglu I. (2010). An ethnobotanical survey of medicinal plants in Sivrice (Elazığ-Turkey). J Ethnopharmacol 132:165-175.
  12. Kültür Ş. (2007). Medicinal plants used in Kırklareli Province (Turkey). J Ethnopharmacol 111:341-364.
  13. Roehm NW, Rodgers GH, Hatfield SM, et al. (1991). An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immun Methods 142:257-265.
  14. Legrand C, Bour JM, J